Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond
Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report
2Pacs Dear Mama Reaches Billboard Top 10 Nearly Three Decades After Release Highlighting Catalog Value
Kevin Warsh Poised for Internal Fed Clash Over Rate Cuts Amid Inflation and Yield Pressure
Berkshire Hathaway Revives Airline Bet with 26 Billion Stake in Delta Air Lines
Contrarian Signal Emerges as Market Timers Rush for Exits
Loop Industries Q1 2026 Earnings Narrowerthanexpected loss amid steady technology development
PCVX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Vaccine Pipeline
Red River Bancshares Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline
AIFF Q3 1998 Earnings Massive EPS Miss as Revenue Remains Unreported
New Pacific Metals Corp NEWP Q1 2026 Earnings EPS Miss Marks Quarter of Operational Progress Amid Narrowing Losses
Exzeo Group Inc XZO Q1 2026 Earnings EPS Beats Estimates by 521 Stock Edges Higher
WD40 Company WDFC Dips 105 as Shares Approach Key Support Level
60 Degrees Pharmaceuticals SXTP Slips 6 as Shares Test Key Support
Corpay Inc CPAY Holds Steady Near Support as Consolidation Continues
Taylor Devices Inc TAYD Edges Higher Nears Key Resistance at 5571
Highlander Silver Corp HSLV Gains 238 as Silver Sector Momentum Builds
Omada Health Q1 2026 Earnings Narrower Loss Beat Estimates as Company Focuses on Operational Efficiency
Radian Group Q1 2026 Earnings BEPS Beat Estimates Despite Broader Market Headwinds
UZD Q1 2026 Earnings EPS Surges Past Estimates by 895 as Digital Infrastructure Demand Holds
CTOS Q1 2026 Earnings EPS Surprises with Smaller Loss but Stock Dips
CMPS Q1 2026 Earnings Loss Narrower Than Expected as Company Advances Clinical Pipeline
CAKE Q1 2026 Earnings EPS Beats Estimates Amid Steady Operations
Japan to Welcome First Crude Cargo via Strait of Hormuz Since Regional Conflict Escalated
ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment
Title Eastern Company EML Holds Steady at 2126 as Support and Resistance Levels Remain Key